Cipla's arm recalling six batches of Albuterol Sulfate inhalation Aerosol in US

10 Jul 2023 Evaluate

Cipla's wholly-owned subsidiary -- Cipla USA Inc is voluntarily recalling the six batches of Albuterol Sulfate inhalation Aerosol 90 mcg, manufactured in November 2021, to the consumer level. The company is initiating a recall in the US due to a market complaint for one single inhaler (batch number - IB20056), where leakage was observed through the inhaler valve.

These six batches were distributed nationwide to wholesalers and retailers. The product is used for the treatment and prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise induced bronchospasm.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.


Cipla Share Price

1481.55 38.35 (2.66%)
22-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1540.30
Dr. Reddys Lab 5872.65
Cipla 1481.55
Zydus Lifesciences 1076.45
Lupin 1712.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.